Neuronetics, Inc. (NASDAQ:STIM) Q1 2024 Earnings Call Transcript

Danny Stauder: Great. And then just one follow-up. Touching back on the clearance in adolescence. Really good to see and you gave some great details on how you’re approaching patient education and outreach here. But just wanted to clarify, how should we be thinking about the impact overall marketing spend? Is this already in your planned budget? Are you just shifting more dollars to this area or will the increase or will it increase the total? Just any more color there you could give would be great. Thank you.

Keith Sullivan: Thanks, Danny. This is Keith. Our marketing spend has been consistent for the last three years. With the Better Me Guarantee Program, we are able to make those same dollars that we’ve been spending more efficient. So, we’re able to market directly around the Better Me Guarantee providers and be able to monitor the patients as they go through the system into their practices and then whether they get treated or not. So, our spend will be consistent with last year and there is not plan to increased that budget.

Operator: This concludes the question and answer session. I would now like to turn it back to Keith Sullivan for closing remarks.

Keith Sullivan: Thank you for your interest in Neuronetics, and we look forward to updating you on our next quarterly call.

Operator: Thank you for your participation in today’s conference. This does conclude the program. You may now disconnect.